Conversely, microcephaly-associated ZNRF3 variants localize to the RSPO-binding domain, conferring resistance to RSPO inhibition and resulting in hyperactive Frizzled degradation, diminished Wnt signaling, reduced NSPC proliferation, and microcephaly [71,72]. The gene discussed is RSPO1; the disease is microcephaly.